ADDARIO LUNG CANCER MEDICAL INSTITUTE
🇺🇸United States
Small Cell Lung Cancer Community Engagement to Eliminate Research Discepancies
Not yet recruiting
- Conditions
- Small-cell Lung Cancer
- First Posted Date
- 2024-07-03
- Last Posted Date
- 2025-04-16
- Lead Sponsor
- Addario Lung Cancer Medical Institute
- Target Recruit Count
- 30
- Registration Number
- NCT06486428
Studying Pathways of Resistance in KRAS-driven Cancers
Recruiting
- Conditions
- KRAS P.G12C
- Interventions
- Diagnostic Test: FoundationOne® Liquid CDx
- First Posted Date
- 2022-03-09
- Last Posted Date
- 2025-04-08
- Lead Sponsor
- Addario Lung Cancer Medical Institute
- Target Recruit Count
- 500
- Registration Number
- NCT05272423
- Locations
- 🇺🇸
Dana-Farber Cancer Institute, Boston, Massachusetts, United States
Biomarker Analysis in High PD-L1 Expressing NSCLC Patients Treated With PD-1/PD-L1 Based Therapy With or Without the Addition of Platinum Based Chemotherapy
Terminated
- Conditions
- NSCLC, Stage IIICNSCLC Stage IV
- Interventions
- Diagnostic Test: Primary Immune Response (PIR) test by Biodesix, Inc.
- First Posted Date
- 2020-12-21
- Last Posted Date
- 2024-02-02
- Lead Sponsor
- Addario Lung Cancer Medical Institute
- Target Recruit Count
- 29
- Registration Number
- NCT04676386
- Locations
- 🇺🇸
Addario Lung Cancer Medical Institute (ALCMI), San Carlos, California, United States
🇺🇸Rush University Medical Center, Chicago, Illinois, United States
Epidemiology of Young Lung Cancer - Survey
Recruiting
- Conditions
- NSCLC
- Interventions
- Other: Online Survey
- First Posted Date
- 2020-11-23
- Last Posted Date
- 2025-04-08
- Lead Sponsor
- Addario Lung Cancer Medical Institute
- Target Recruit Count
- 250
- Registration Number
- NCT04640259
- Locations
- 🇺🇸
USC Keck School of Medicine, Los Angeles, California, United States
🇺🇸Addario Lung Cancer Medical Institute, San Carlos, California, United States
PDX Models From EGFR Mutant Tumors
Withdrawn
- Conditions
- Non Small Cell Lung Cancer
- First Posted Date
- 2019-03-13
- Last Posted Date
- 2020-01-09
- Lead Sponsor
- Addario Lung Cancer Medical Institute
- Registration Number
- NCT03872440
- Locations
- 🇺🇸
Addario Lung Cancer Medical Institute, San Carlos, California, United States
Study of Plasma NGS for Assessment, Characterization, Evaluation of Patients With ALK Resistance
Completed
- Conditions
- Non-Small Cell Lung Cancer
- Interventions
- Diagnostic Test: Plasma Next Generation Sequencing (NGS)
- First Posted Date
- 2019-02-07
- Last Posted Date
- 2025-01-13
- Lead Sponsor
- Addario Lung Cancer Medical Institute
- Target Recruit Count
- 120
- Registration Number
- NCT03833934
- Locations
- 🇺🇸
Dana-Farber Cancer Institute, Boston, Massachusetts, United States
Role of Circulating Tumor DNA (ctDNA) From LIquid Biopsy in Early Stage NSCLC Resected Lung Tumor Investigation
Terminated
- Conditions
- Non Small Cell Lung Cancer
- First Posted Date
- 2018-06-12
- Last Posted Date
- 2020-11-19
- Lead Sponsor
- Addario Lung Cancer Medical Institute
- Target Recruit Count
- 38
- Registration Number
- NCT03553550
- Locations
- 🇺🇸
Washington University School of Medicine, Saint Louis, Missouri, United States
🇺🇸Northside Hospital, Atlanta, Georgia, United States
🇺🇸Rush University Medical Center, Chicago, Illinois, United States
ALCMI-006: A Prospective Biospecimen Collection Study From Patients With ROS1-Fusion Positive Tumors
Completed
- Conditions
- ROS1-fusion Positive Tumor
- First Posted Date
- 2018-04-13
- Last Posted Date
- 2020-09-09
- Lead Sponsor
- Addario Lung Cancer Medical Institute
- Target Recruit Count
- 5
- Registration Number
- NCT03497624
- Locations
- 🇺🇸
ALCMI, San Carlos, California, United States
Collaborative Advanced Stage Tissue Lung Cancer (CASTLE) Network
Terminated
- Conditions
- Non-small Cell Lung Cancer MetastaticSmall Cell Lung Carcinoma
- Interventions
- Other: therapeutic interventions
- First Posted Date
- 2012-04-10
- Last Posted Date
- 2020-01-10
- Lead Sponsor
- Addario Lung Cancer Medical Institute
- Target Recruit Count
- 136
- Registration Number
- NCT01574300
© Copyright 2025. All Rights Reserved by MedPath